RSCI
Price
$0.07
Change
-$0.10 (-58.82%)
Updated
May 13 closing price
Capitalization
N/A
SGIOF
Price
$16.81
Change
+$0.61 (+3.77%)
Updated
Jul 25 closing price
Capitalization
12.4B
Interact to see
Advertisement

RSCI vs SGIOF

Header iconRSCI vs SGIOF Comparison
Open Charts RSCI vs SGIOFBanner chart's image
Redwood Scientific Technologies
Price$0.07
Change-$0.10 (-58.82%)
Volume$13.39K
CapitalizationN/A
Shionogi & Co
Price$16.81
Change+$0.61 (+3.77%)
Volume$1.22K
Capitalization12.4B
RSCI vs SGIOF Comparison Chart in %
Loading...
RSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCI vs. SGIOF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCI is a Hold and SGIOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (RSCI: $0.07 vs. SGIOF: $16.81)
Brand notoriety: RSCI and SGIOF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RSCI: 100% vs. SGIOF: 105%
Market capitalization -- RSCI: $0 vs. SGIOF: $12.4B
RSCI [@Pharmaceuticals: Other] is valued at $0. SGIOF’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCI’s FA Score shows that 0 FA rating(s) are green whileSGIOF’s FA Score has 2 green FA rating(s).

  • RSCI’s FA Score: 0 green, 5 red.
  • SGIOF’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOF is a better buy in the long-term than RSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSCI’s TA Score shows that 2 TA indicator(s) are bullish while SGIOF’s TA Score has 4 bullish TA indicator(s).

  • RSCI’s TA Score: 2 bullish, 0 bearish.
  • SGIOF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, RSCI is a better buy in the short-term than SGIOF.

Price Growth

RSCI (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SGIOF (@Pharmaceuticals: Other) price change was +6.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOF YTD gains are higher at: 37.674 vs. RSCI (-32.432).
RSCISGIOFRSCI / SGIOF
CapitalizationN/A12.4B-
EBITDAN/A242B-
Gain YTD-32.43237.674-86%
P/E RatioN/A9.57-
RevenueN/A427B-
Total CashN/A563B-
Total DebtN/A9.41B-
FUNDAMENTALS RATINGS
RSCI vs SGIOF: Fundamental Ratings
RSCI
SGIOF
OUTLOOK RATING
1..100
4390
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1002
PRICE GROWTH RATING
1..100
9251
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
546

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOF's Valuation (26) in the null industry is in the same range as RSCI (36). This means that SGIOF’s stock grew similarly to RSCI’s over the last 12 months.

SGIOF's Profit vs Risk Rating (100) in the null industry is in the same range as RSCI (100). This means that SGIOF’s stock grew similarly to RSCI’s over the last 12 months.

SGIOF's SMR Rating (2) in the null industry is significantly better than the same rating for RSCI (100). This means that SGIOF’s stock grew significantly faster than RSCI’s over the last 12 months.

SGIOF's Price Growth Rating (51) in the null industry is somewhat better than the same rating for RSCI (92). This means that SGIOF’s stock grew somewhat faster than RSCI’s over the last 12 months.

SGIOF's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for RSCI (100). This means that SGIOF’s stock grew somewhat faster than RSCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSCISGIOF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JGRO88.000.50
+0.57%
JPMorgan Active Growth ETF
USSG58.800.30
+0.51%
Xtrackers MSCI USA Selection Eq ETF
SECR25.810.05
+0.18%
NYLI MacKay Securitized Income ETF
NUSA23.300.03
+0.13%
Nuveen ESG 1-5 Year US Aggt Bd ETF
IFV23.72N/A
+0.02%
First Trust Dorsey Wright Intl Foc 5

RSCI and

Correlation & Price change

A.I.dvisor tells us that RSCI and ETST have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCI and ETST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCI
1D Price
Change %
RSCI100%
N/A
ETST - RSCI
22%
Poorly correlated
N/A
RAFA - RSCI
7%
Poorly correlated
N/A
SGIOF - RSCI
6%
Poorly correlated
+3.77%
TEVJF - RSCI
5%
Poorly correlated
N/A
SBFM - RSCI
5%
Poorly correlated
+1.28%
More

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and AGYTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and AGYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
+3.77%
AGYTF - SGIOF
25%
Poorly correlated
N/A
HLNCF - SGIOF
21%
Poorly correlated
-0.51%
SFOSF - SGIOF
11%
Poorly correlated
N/A
ROMJF - SGIOF
8%
Poorly correlated
+0.53%
TEVJF - SGIOF
8%
Poorly correlated
N/A
More